Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Wurschi, Georg [VerfasserIn]   i
 Rühle, Alexander [VerfasserIn]   i
 Domschikowski, Justus [VerfasserIn]   i
 Trommer, Maike [VerfasserIn]   i
 Ferdinandus, Simone [VerfasserIn]   i
 Becker, Jan-Niklas [VerfasserIn]   i
 Böke, Simon [VerfasserIn]   i
 Sonnhoff, Mathias [VerfasserIn]   i
 Fink, Christoph Andreas [VerfasserIn]   i
 Käsmann, Lukas [VerfasserIn]   i
 Schneider, Melanie [VerfasserIn]   i
 Bockelmann, Elodie [VerfasserIn]   i
 Krug, David [VerfasserIn]   i
 Nicolay, Nils [VerfasserIn]   i
 Fabian, Alexander [VerfasserIn]   i
 Pietschmann, Klaus [VerfasserIn]   i
Titel:Patient-relevant costs for organ preservation versus radical resection in locally advanced rectal cancer
Verf.angabe:Georg W. Wurschi, Alexander Rühle, Justus Domschikowski, Maike Trommer, Simone Ferdinandus, Jan-Niklas Becker, Simon Boeke, Mathias Sonnhoff, Christoph A. Fink, Lukas Käsmann, Melanie Schneider, Elodie Bockelmann, David Krug, Nils H. Nicolay, Alexander Fabiana and Klaus Pietschmann
E-Jahr:2024
Jahr:26 March 2024
Umfang:18 S.
Illustrationen:Illustrationen
Fussnoten:Gesehen am 08.10.2024
Titel Quelle:Enthalten in: Cancers
Ort Quelle:Basel : MDPI, 2009
Jahr Quelle:2024
Band/Heft Quelle:16(2024), 7, Artikel-ID 1281, Seite 1-18
ISSN Quelle:2072-6694
Abstract:Total neoadjuvant therapy (TNT) is an evolving treatment schedule for locally advanced rectal cancer (LARC), allowing for organ preservation in a relevant number of patients in the case of complete response. Patients who undergo this so-called “watch and wait” approach are likely to benefit regarding their quality of life (QoL), especially if definitive ostomy could be avoided. In this work, we performed the first cost-effectiveness analysis from the patient perspective to compare costs for TNT with radical resection after neoadjuvant chemoradiation (CRT) in the German health care system. Individual costs for patients insured with a statutory health insurance were calculated with a Markov microsimulation. A subgroup analysis from the prospective “FinTox” trial was used to calibrate the model’s parameters. We found that TNT was less expensive (−1540 EUR) and simultaneously resulted in a better QoL (+0.64 QALYs) during treatment and 5-year follow-up. The average cost for patients under TNT was 4711 EUR per year, which was equivalent to 3.2% of the net household income. CRT followed by resection resulted in higher overall costs for ostomy care, medication and greater loss of earnings. Overall, TNT appeared to be more efficacious and cost-effective from a patient’s point of view in the German health care system.
DOI:doi:10.3390/cancers16071281
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.3390/cancers16071281
 Volltext: https://www.mdpi.com/2072-6694/16/7/1281
 DOI: https://doi.org/10.3390/cancers16071281
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:cost-effectiveness
 financial toxicity
 rectal cancer
 total neoadjuvant therapy
 watch and wait
K10plus-PPN:1905058462
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69260318   QR-Code
zum Seitenanfang